rethinkTHC Search
Menu
Study breakdown

A serotonin gene variant influenced brain response to cannabis treatment in adolescents

Randomized Controlled TrialPreliminary evidence
The takeaway

A serotonin receptor gene polymorphism (rs6311) was associated with different brain activation patterns in adolescents after psychosocial treatment for cannabis use disorders.

Read this if you are interested in how genetics might influence addiction treatment response.

Serotonin receptor gene variant linked to treatment-related brain changes

What the researchers found

This preliminary study examined whether genetic variations in the serotonin system moderated brain responses to psychosocial treatment for adolescent cannabis use disorders. Two serotonin gene polymorphisms were tested: a receptor variant (rs6311) and a transporter variant (rs2020936).

The original hypotheses were not supported. However, the rs6311 C allele was significantly associated with brain activation in the medial frontal gyrus and precuneus after treatment, suggesting this serotonin receptor variant plays a role in how adolescent brains respond to cannabis treatment.

These regions are involved in self-reflection and internal processing, suggesting the genetic variant may influence treatment-related changes in self-awareness and motivation.

Why it matters

If genetic variants predict treatment response, future cannabis treatment could be personalized based on individual biology. The serotonin system connection also explains why anxiety and depression commonly co-occur with cannabis use disorders.

The numbers in context

Two polymorphisms tested: rs6311 (serotonin receptor) and rs2020936 (transporter). rs6311 C allele associated with activation in medial frontal gyrus and precuneus.

How the study worked

fMRI study of adolescents with cannabis use disorders following psychosocial treatment. Participants were genotyped for serotonin receptor (rs6311) and transporter (rs2020936) polymorphisms. Brain activation patterns were compared across genotypes.

What this study cannot tell us

Preliminary study with small sample size. Original hypotheses were not supported. Single gene variant findings require replication. Could not determine whether the brain differences predicted actual treatment outcomes.

How to read the evidence

Preliminary fMRI pharmacogenomic study. Exploratory analysis after original hypotheses were unsupported. Requires replication in larger samples.

When this study was published

Published in 2012. Pharmacogenomics in addiction treatment remains an emerging field.

The bigger picture

Pharmacogenomics in addiction treatment is in its early stages. This study provided initial evidence that genetic factors might influence not just susceptibility to cannabis problems but also response to treatment.

Questions still open

  • Does the rs6311 variant predict long-term treatment success? Would medications targeting the serotonin system enhance treatment for cannabis use disorders in carriers? Can pharmacogenomic testing guide treatment selection?

Common questions

Could genetic testing improve cannabis treatment?
This early study found one serotonin gene variant influenced brain responses to treatment. While promising conceptually, the finding is preliminary and genetic testing is not yet practical for guiding cannabis treatment decisions.
Why would serotonin genes matter for cannabis treatment?
Depression and anxiety commonly co-occur with cannabis use disorders, and the serotonin system is central to mood regulation. Genetic variations in serotonin function may influence how well someone responds to treatment by affecting motivation, self-reflection, and emotional processing.

Read the original research

A preliminary examination of how serotonergic polymorphisms influence brain response following an adolescent cannabis intervention.

Psychiatry research, 204(2-3), 112-6

Citation

Feldstein Ewing, Sarah W; Mead, Hilary K; Yezhuvath, Uma; Dewitt, Sam; Hutchison, Kent E; Filbey, Francesca M. (2012). A preliminary examination of how serotonergic polymorphisms influence brain response following an adolescent cannabis intervention.. Psychiatry research, 204(2-3), 112-6. https://doi.org/10.1016/j.pscychresns.2012.10.011

Explore the wider topic